We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 4,200 results
  1. Defining type 2 diabetes polygenic risk scores through colocalization and network-based clustering of metabolic trait genetic associations

    Background

    Type 2 diabetes (T2D) is a heterogeneous and polygenic disease. Previous studies have leveraged the highly polygenic and pleiotropic nature...

    Samuel Ghatan, Jeroen van Rooij, ... Ling Oei in Genome Medicine
    Article Open access 10 January 2024
  2. Association between genetically proxied lipid-lowering drug targets, lipid traits, and amyotrophic lateral sclerosis: a mendelian randomization study

    Background

    The use of circulating lipid traits as biomarkers to predict the risk of amyotrophic lateral sclerosis (ALS) is currently controversial,...

    Zhaoqi Yan, Yifeng Xu, ... Liangji Liu in Acta Neurologica Belgica
    Article 27 October 2023
  3. Genetic association of lipid traits and lipid-related drug targets with normal tension glaucoma: a Mendelian randomization study for predictive preventive and personalized medicine

    Background

    Glaucoma is the leading cause of irreversible blindness worldwide. Normal tension glaucoma (NTG) is a distinct subtype characterized by...

    Tianyi Kang, Yi Zhou, ... Jian Jiang in EPMA Journal
    Article 13 July 2024
  4. Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study

    Background

    Melanoma proliferation is partly attributed to dysregulated lipid metabolism. The effectiveness of lipid-lowering drugs in combating...

    Lusheng Miao, Taosheng Miao, ... ** Hao in BMC Cancer
    Article Open access 17 May 2024
  5. Cell-type-specific and disease-associated expression quantitative trait loci in the human lung

    Common genetic variants confer substantial risk for chronic lung diseases, including pulmonary fibrosis. Defining the genetic control of gene...

    Heini M. Natri, Christina B. Del Azodi, ... Nicholas E. Banovich in Nature Genetics
    Article Open access 28 March 2024
  6. Repurposing lipid-lowering drugs on asthma and lung function: evidence from a genetic association analysis

    Objective

    To explore the correlation between asthma risk and genetic variants affecting the expression or function of lipid-lowering drug targets.

    ...
    Yue Zhang, Zichao Jiang, ... **angrong Zheng in Journal of Translational Medicine
    Article Open access 03 July 2024
  7. EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression

    Prostate cancer (PCa) is one of the most common malignant tumors affecting the male genitourinary system. However, there is currently a lack of...

    Zefeng Wang, Zheng Chao, ... Fan Cheng in Journal of Translational Medicine
    Article Open access 26 January 2024
  8. MEF2C regulates NK cell effector functions through control of lipid metabolism

    Natural killer (NK) cells are a critical first line of defense against viral infection. Rare mutations in a small subset of transcription factors can...

    Joey H. Li, Adalia Zhou, ... Timothy E. O’Sullivan in Nature Immunology
    Article 08 April 2024
  9. Novel autosomal dominant TMC1 variants linked to hearing loss: insight into protein-lipid interactions

    Background

    TMC1 , which encodes transmembrane channel-like protein 1, forms the mechanoelectrical transduction (MET) channel in auditory hair cells,...

    Sung Ho Cho, Ye** Yun, ... Sang-Yeon Lee in BMC Medical Genomics
    Article Open access 08 December 2023
  10. Drug Delivery Systems: Lipid Nanoparticles Technology in Clinic

    Drug delivery systems (DDS) aid the administration of therapeutic cargoes to desired tissues to evoke a pharmacological response with minimal adverse...
    Saloni Andhari, Rituja Gupta, Jayant Khandare in The Quintessence of Basic and Clinical Research and Scientific Publishing
    Chapter 2023
  11. Discovery and Exploration of Lipid-Modifying Drug Targets for ALS by Mendelian Randomization

    Observational studies have faced challenges in identifying replicable causes for amyotrophic lateral sclerosis (ALS). To address this, we employed an...

    Zheng Jiang, **ao-**g Gu, ... Yong-** Chen in Molecular Neurobiology
    Article 07 February 2024
  12. Circulating lipids, lipid-lowering drug targets, and breast cancer risk: Comprehensive evidence from Mendelian randomization and summary data-based Mendelian randomization

    Background

    Breast cancer (BC) is the most common and fatal cancer among women, yet the causal relationship between circulating lipids, lipid-lowering...

    Zhongxu Zhang, Daxin Zhang in Cancer Causes & Control
    Article 02 March 2024
  13. Transcriptomics of differences in thermal plasticity associated with selection for an exaggerated male sexual trait

    The information about the magnitude of differences in thermal plasticity both between and within populations, as well as identification of the...

    Agata Plesnar-Bielak, Jonathan M. Parrett, ... Mateusz Konczal in Heredity
    Article 27 May 2024
  14. The combination of machine learning and untargeted metabolomics identifies the lipid metabolism -related gene CH25H as a potential biomarker in asthma

    Background

    Lipids, significant signaling molecules, regulate a multitude of cellular responses and biological pathways in asthma which are closely...

    Xuexuan Ding, **gtong Qin, ... Lianxiang Luo in Inflammation Research
    Article 20 April 2023
  15. ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma

    Background

    Clear cell renal cell carcinoma (ccRCC), the predominant subtype of kidney cancer, possesses characteristic alterations to multiple...

    Timothy D. Klasson, Edward L. LaGory, ... Amato J. Giaccia in Cancer & Metabolism
    Article Open access 03 October 2022
  16. Whole-exome sequencing identifies novel protein-altering variants associated with serum apolipoprotein and lipid concentrations

    Background

    Dyslipidemia is a major risk factor for cardiovascular disease, and diabetes impacts the lipid metabolism through multiple pathways. In...

    Niina Sandholm, Ronja Hotakainen, ... Per-Henrik Groop in Genome Medicine
    Article Open access 23 November 2022
  17. On the Feasibility of Rugose Lipid Microparticles in Pressurized Metered Dose Inhalers with Established and New Propellants

    Pressurized metered dose inhalers (pMDIs) require optimized formulations to provide stable, consistent lung delivery. This study investigates the...

    Zahra Minootan, Hui Wang, ... Reinhard Vehring in AAPS PharmSciTech
    Article 10 April 2024
  18. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer

    Background

    Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with high probability of recurrence and distant metastasis. Liver metastasis...

    **aohong Liu, Bo Ren, ... Yupei Zhao in Journal of Translational Medicine
    Article Open access 29 April 2024
  19. Cancer and Lipid Metabolism: Roles of Adipocytes on Tumor Microenvironment

    The tumor microenvironment is a complex structure surrounding cancer cells with various cell types, involving stromal and immune cells, including...
    Dinh-Toi Chu, Quang Huy Nguyen, ... Bao Anh Cao in Handbook of Cancer and Immunology
    Living reference work entry 2022
  20. Super-Resolution Imaging of Intracellular Lipid Nanocarriers to Study Drug Delivery in Photodynamic Therapy

    Liposomal nanocarriers are intensively investigated as delivery vehicles for photoactivatable agents used in photodynamic therapy (PDT). The uptake,...
    Enzo M. Scutigliani, Jakub A. Kochan, ... Przemek M. Krawczyk in Photodynamic Therapy
    Protocol 2022
Did you find what you were looking for? Share feedback.